Hospital Executive FAQ's
Currently, SonaCare Medical limits the number of locations to a total of three. To learn more about mobilization for your HIFU practice please see the "contact us" page of our website.
Sonablate is indicated for transrectal high intensity focused ultrasound (HIFU) ablation of prostatic tissue.
Sonatherm is indicated for the laparoscopic or intraoperative ablation of soft tissue from the ultrasound focal zone back to the surface of the targeted ablation area in General Surgery. The Sonatherm is not to be used for non-invasive ablation, i.e. leaving intervening tissue spared, and it is not indicated for the ablation of Prostate tissue.
Sonablate does not work directly in an MRI environment. It does provide support for MRI/US fusion systems that have been developed to support MRI guided biopsies. SonaCare Medical has adapted the fusion algorithms developed by select third parties and implemented them in the Sonablate planning system, so that regions of interest identified on an MRI can be overlaid in correct locations on an intraoperative ultrasound image generated at the time of delivering a focused ultrasound ablation.
Sonablate HIFU is currently a cash pay procedure; there is no formal reimbursement by any of the major insurance carriers or Medicare. That said, there have been isolated instances of insurance payments to clients who have filed a claim after the procedure has been delivered, mostly through regional BlueCross/BlueShield.
SonaCare Medical is exploring a range of options associated with securing coverage, such as collaborative efforts with other interested parties, including the Focused Ultrasound Foundation.
There currently exists a number of codes for use with a laparoscopic ablation specifically related to kidney. Please consult your sales specialist for details.